Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.
| Image |  |
|---|---|
| Description | scientific article published on 11 February 2008 |
| Author/s |
author: Carsten Bokemeyer |
| Publication date | February 11, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |